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The recent study by Mehra et al. (1) in the Journal contains the
following sentence: “The severity of CHF was categorized by New
York Heart Association (NYHA) functional class criteria, etc.” (1).
It exemplifies a common practice in the current professional
literature dealing with heart failure to use the NYHA functional
classification as a system for grading the severity of heart failure.
Such statements are not correct. The NYHA functional classifi-
cation has never been proposed as a method for grading the
severity of heart failure. This classification (2) is an imprecise,
nonquantified exercise tolerance test in which the exercise is listed
as “ordinary physical activity” (not further defined) and the end
points are one or more of the following symptoms: undue fatigue,
palpitation, shortness of breath, and anginal syndrome. Thus,
patients with heart disease who are in class 1 are capable of
performing “ordinary physical activity” without experiencing any of
the listed symptoms; those in class 2 do experience one or more of
the symptoms during “ordinary physical activity”; those in class 3
experience one or more of these symptoms when performing
exercise that is less strenuous than “ordinary physical activity”;
those in class 4 experience one or more of these symptoms at rest.
The four-symptom end points listed above are common in patients
with heart disease, but they are not specific for heart failure. They
are not synonymous with heart failure, and in none of the official
publications of the NYHA describing the functional classification
in its present form, initially published in 1943 (3), are the words
“heart failure” used. The functional classification provides a clini-
cally useful, although crude, estimate of a patient’s exercise
capacity. It is a conceptual and linguistic distortion to transform
the simple exercise algorithm into the complex and multifaceted
concept of heart failure.
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REPLY
“Though this be madness, yet there is a method in’t.”
William Shakespeare
In principle, we agree with Dr. Dolgin that the New York Heart
Association (NYHA) functional classification represents an impre-
cise but useful tool to assess exercise tolerance in patients with
heart disease but that it was not intended for evaluating the severity
of heart failure. However, time has stood witness to the importance
of the NYHA functional class as a powerful discriminator of
symptoms and prognosis in heart failure (1). As symptoms advance
in heart failure, so does the gravity of prognosis. Because the
NYHA functional classification system distinguishes severity of
symptoms, it has been extrapolated in common parlance as a
parameter to assess heart failure severity. To overcome this
common misperception and largely because patients transit back
and forth among various NYHA functional classes, Hunt et al. (2)
have recently proposed a staging system for heart failure that
incorporates the NYHA functional class as a symptom surrogate,
the presence of which places the patient at a more advanced stage
of disease.
The need to establish reliable indicators of prognosis and
accurate risk stratification parameters in heart failure is of para-
mount clinical importance. Various heart failure severity scores
incorporate the NYHA system functional classification as an
important variable (3). In our study (4), we were careful to not only
assess the NYHA functional class but also to simultaneously
include evaluations of echocardiographic findings, peak oxygen
uptake by cardiopulmonary stress testing, and to measure cytokines
related to severity of heart failure. Furthermore, owing to the poor
interobserver variability of NYHA functional classification esti-
mates, some have even gone a step further to propose newer
functional classification systems that decrease the inherent vari-
ability of this measurement (5). Thus, we admit that the NYHA
functional classification is a crude but practical and important
measurement of symptom severity in heart failure. Shakespeare
said it best in Hamlet: “There is nothing either good or bad, but
thinking makes it so.”
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